Abstract

Understanding how to controllably modulate the efficiency of energy transfer in Förster resonance energy transfer (FRET)-based assemblies is critical to their implementation as sensing modalities. This is particularly true for sensing assemblies that are to be used as the basis for real time intracellular sensing of intracellular processes and events. We use a quantum dot (QD) donor -mCherry acceptor platform that is engineered to self-assemble in situ wherein the protein acceptor is expressed via transient transfection and the QD donor is microinjected into the cell. QD-protein assembly is driven by metal-affinity interactions where a terminal polyhistidine tag on the protein binds to the QD surface. Using this system, we show the ability to modulate the efficiency of the donor–acceptor energy transfer process by controllably altering either the ligand coating on the QD surface or the precise location where the QD-protein assembly process occurs. Intracellularly, a short, zwitterionic ligand mediates more efficient FRET relative to longer ligand species that are based on the solubilizing polymer, poly(ethylene glycol). We further show that a greater FRET efficiency is achieved when the QD-protein assembly occurs free in the cytosol compared to when the mCherry acceptor is expressed tethered to the inner leaflet of the plasma membrane. In the latter case, the lower FRET efficiency is likely attributable to a lower expression level of the mCherry acceptor at the membrane combined with steric hindrance. Our work points to some of the design considerations that one must be mindful of when developing FRET-based sensing schemes for use in intracellular sensing.

Highlights

  • Increasing the efficacy of theranostic probes, those that can simultaneously sense/report on as well as treat a disease state, is currently a major focus of biomedical research [1,2]

  • Our goal in this study was to assess the ability to control the intracellular Förster resonance energy transfer (FRET) efficiency of a quantum dot (QD)-mCherry donor–acceptor assembly by modulating the ligand coating on the QD donor while simultaneously site- expressing the mCherry acceptor to control the location of the in situ assembled QD-mCherry complex

  • We subsequently employed microinjection of the QD donor coupled with transient transfection/expression of the mCherry acceptor to determine the efficiency of site-specific intracellular FRET

Read more

Summary

Introduction

Increasing the efficacy of theranostic probes, those that can simultaneously sense/report on as well as treat a disease state, is currently a major focus of biomedical research [1,2]. Various approaches have been employed here and these have ranged from the cellular delivery of fluorophore conjugates directed to epitope tags expressed on targeted proteins to the recombinant expression of the fluorophore tag as a fusion to the protein of interest. A still further example described by Lee et al used a fluorescent molecular beacon reporter construct comprising a masking/quenching protein, a mitochondrial targeting sequence, a protease-specific cleavage sequence and a GFP reporter [9]. This sensing construct reported on both the location and activity level of matrix metalloproteases in living cells

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.